Eastwood Bio-Medical Canada Receivables

Eastwood Bio-Medical Canada's receivables stands at $37K as of July 2024. That compares with $25K in the prior-year period — up 51.0% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Eastwood Bio-Medical Canada reported $37K in receivables versus $25K a year earlier — a 51.0% year-over-year increase. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

That compares with $25K in the prior-year period — up 51.0% year over year. Sustained growth in receivables can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how Eastwood Bio-Medical Canada's receivables evolved across reporting periods, while the comparison chart places EWOOF next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.